Valuation: GKB Ophthalmics Limited

Market Cap 265M 2.75M 2.41M 2.24M 2.06M 3.87M 3.93M 26.65M 10.41M 130M 10.32M 10.09M 450M P/E 2024
-15.6x
P/E 2025 -4.32x
Enterprise Value 280M 2.91M 2.56M 2.38M 2.18M 4.1M 4.16M 28.22M 11.03M 138M 10.92M 10.69M 476M EV / Sales 2024
0.43x
EV / Sales 2025 0.29x
Free-Float
21.95%
Yield 2024 *
-
Yield 2025 -
05-27 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
02-12 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
11-14 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
25-08-14 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
25-05-30 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
25-02-13 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
24-11-14 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
24-08-13 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
24-05-30 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
24-03-19 GKB Ophthalmics Limited Announces Resignation of Subhash Redkar as Executive Director / Whole Time Director CI
24-02-14 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
23-11-14 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
23-08-11 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
1 day+4.34%
1 week+0.35%
Current month-10.58%
1 month-10.24%
3 months-15.83%
6 months-0.16%
Current year+12.20%
1 week 55.1
Extreme 55.1
60.24
1 month 55.1
Extreme 55.1
64.9
Current year 48.15
Extreme 48.15
76.9
1 year 45.25
Extreme 45.25
91.7
3 years 45.25
Extreme 45.25
136.4
5 years 45.25
Extreme 45.25
197.9
10 years 28.35
Extreme 28.35
209.2
Manager TitleAgeSince
Chief Executive Officer 84 1981-12-09
Director of Finance/CFO - 2019-03-31
Chief Administrative Officer 62 2024-05-31
Director TitleAgeSince
Chairman 84 1981-12-09
Director/Board Member 57 1996-07-23
Director/Board Member 68 2023-06-19
Change 5-day change 1-year change 3-year change Capi.($)
+4.34%+0.35%-22.33%-33.31% 3.01M
+0.99%-1.92%-34.52%-5.49% 85.56B
+1.90%-1.69%-23.35%-23.43% 33.28B
+0.11%-1.95%-5.74%-27.79% 13.71B
-0.27%+3.48% - - 10.04B
-0.27%+2.89%-32.06%+482.44% 1.81B
-4.61%-4.09%-41.27%-67.99% 1.4B
-3.40%-6.73%-41.44%-33.18% 801M
-1.34%-1.04%+3.11%-10.41% 787M
+3.46%+1.65%+47.49%-30.70% 759M
Average +0.07%-1.90%-16.68%+27.79% 14.81B
Weighted average by Cap. +0.94%-1.57%-28.38%-6.58%

Financials

2024 2025
Net sales 883M 9.16M 8.05M 7.49M 6.87M 12.91M 13.11M 88.89M 34.73M 434M 34.4M 33.66M 1.5B 1.09B 11.32M 9.94M 9.24M 8.48M 15.94M 16.18M 110M 42.89M 536M 42.49M 41.57M 1.85B
Net income -28.1M -292K -256K -238K -219K -411K -417K -2.83M -1.11M -13.82M -1.1M -1.07M -47.77M -70.45M -732K -643K -598K -548K -1.03M -1.05M -7.1M -2.77M -34.63M -2.75M -2.69M -120M
Net Debt -57.22M -594K -522K -485K -445K -837K -850K -5.76M -2.25M -28.13M -2.23M -2.18M -97.26M 15.59M 162K 142K 132K 121K 228K 232K 1.57M 613K 7.67M 608K 595K 26.5M
Logo GKB Ophthalmics Limited
GKB Ophthalmics Limited is engaged in manufacturing and sale of unfinished ophthalmic lenses. The Company is also focused on the business of manufacturing and supply of semi-finished plastic lenses. The Company operates through the Ophthalmics Lenses segment. Its products consist of organic semifinished lenses, which include single vision, bifocal, progressive and aspheric lenses. The single vision lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 CLEAR, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE, 1.50 Q-SHADE+ and 1.50 SUNSENSOR. Its bifocal lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE and 1.50 Q-SHADE+. Its progressive lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 DAYNITE and 1.56 DAYNITE FAST CHANGE. Its aspheric lens includes 1.498 CR-39. The Company’s products are exported to various countries across the globe. Its subsidiaries include GSV Ophthatmics Private Limited, GKB Ophthalmics Products FZE, and others.
Employees
170
Date Price Change Volume
26-07-24 ₹57.49 +4.34% 291
26-07-23 ₹55.10 -4.19% 402
26-07-22 ₹57.51 -3.56% 103
26-07-21 ₹59.63 +0.29% 1,683
26-07-20 ₹59.46 +3.79% 127